Molecular Biology Reports

, Volume 39, Issue 2, pp 1163–1172

Antiviral role of toll-like receptors and cytokines against the new 2009 H1N1 virus infection

Article

Abstract

People are generally susceptible to the 2009 new mutate of H1N1 influenza due to lack of appropriate immunity. Influenza H1N1 2009 infection triggers a massive inflammatory response that contributes to fever, lung impairment or other tissue damage, eventually leading to death. Infection with pathogenic influenza virus H1N1 induces severe pulmonary immune pathology. To date, more than 10,000 cases worldwide have died of the disease. It still has strong infectious ability although the mortality of influenza isn’t currently high. Therefore, to explore the pathogenesis of H1N1 influenza can help with the disease prevention, diagnosis and provide a theoretical basis and the new ideas of treatment. Laboratory confirmed cases of pandemic influenza H1N1 2009 were enrolled to collect general information on pre-clinical, clinical and laboratory data for analysis. Blood samples were obtained from patients with H1N1, healthy volunteers and patients with bacterial pneumonia. Serum were separated and collected. RT–PCR and ELISA methods were applied to detect the different expression of TLRs and cytokines. The young, pregnant and postpartum women and infant are highly susceptible to influenza H1N1 2009 infection; degree of susceptibility is not associated with BMI. Biochemical changes can be seen in the patients with influenza H1N1 2009 infection: ALT, AST, CK, LDH increased in varying degrees. TLR2, TLR3, TLR9 expression increased in the patients with influenza H1N1 2009 infection; no obvious changes of TLR4, TLR7, TLR8 can be detected. In pregnant and postpartum women group, only TLR9 expression increased. The expression of IL-2, IL-6, IFN-γ, TNF-α in the patients with influenza H1N1 2009 infection was significantly increased; while IL-10 expression decreased and IL-4 expression did not change. H1N1 influenza-infected pregnant and postpartum women group, only IL-2 and TNF-α expression expression increased, other cytokines decreased or didn’t change. TLR2, TLR3, TLR9 are the major members of TLR family in the recognition of the novel H1N1 virus to start the innate immune response and adaptive immune responses. TLR9 may be the key receptor among pattern recognized receptors to recognize and bind to H1N1 virus. Cellular immune responses induced by Th1 may participate in modulating the influenza H1N1 2009.

Keywords

H1N1 Toll-like receptor Cytokine Immune Th1 

References

  1. 1.
    McCullers JA (2006) Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571–582PubMedCrossRefGoogle Scholar
  2. 2.
    Hilleman MR (2002) Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20:3068–3087PubMedCrossRefGoogle Scholar
  3. 3.
    Webster RG, Govorkova EA (2006) H5N1 influenza-continuing evolution and spread. N Engl J Med 355:2174–2177PubMedCrossRefGoogle Scholar
  4. 4.
    Perez-Padilla R, de la Rosa-Zamboni D et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361(7):680–689PubMedCrossRefGoogle Scholar
  5. 5.
    Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197–201PubMedCrossRefGoogle Scholar
  6. 6.
    Van der Meer FJ, Orsel K, Barkema HW (2010) The new influenza A H1N1 virus: balancing on the interface of humans and animals. Can Vet J 51(1):56–62PubMedGoogle Scholar
  7. 7.
    Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS et al (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615PubMedCrossRefGoogle Scholar
  8. 8.
    Shahsavandi S, Salmanian AH, Ghorashi SA et al (2010) Specific subtyping of Influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus. Mol Biol Rep 38(5):3293–3298PubMedCrossRefGoogle Scholar
  9. 9.
    Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361:680–689PubMedCrossRefGoogle Scholar
  10. 10.
    Zhang C, Wu X, Zhao Y, Deng Z, Qian G (2011) SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells. Mol Biol Rep 38(1):601–609PubMedCrossRefGoogle Scholar
  11. 11.
    Guillot L, Goffic RL, Bloch S et al (2005) Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double stranded RNA and influenza A virus. J Biol Chem 280:5571–5580PubMedCrossRefGoogle Scholar
  12. 12.
    Liu L, Botos I, Wang Y et al (2008) Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320:379–381PubMedCrossRefGoogle Scholar
  13. 13.
    Doherty PC, Turner SJ, Webby RG, Thomas PG (2006) Influenza and the challenge for immunology. Nat Immunol 7:449–455PubMedCrossRefGoogle Scholar
  14. 14.
    Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M et al (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319–323PubMedCrossRefGoogle Scholar
  15. 15.
    World Health Organization (2009) Global alert and response, pandemic (H1N1) 2009, frequently asked questions: what is phase 6? http://www.who.int/csr/disease/swineflu/frequently_asked_questions/levels_pandemic_alert/en/index.html. Accessed 8 Oct
  16. 16.
    Centers for Disease Control, Prevention (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58(19):521–524Google Scholar
  17. 17.
    Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 302(17):1896–1902PubMedCrossRefGoogle Scholar
  18. 18.
    Dessing MC, van der Sluijs KF, Florquin S, Akira S, van der Poll T (2007) Toll-like receptor 2 does not contribute to host response during post influenza pneumococcal pneumonia. Am J Respir Cell Mol Biol 36(5):609–614PubMedCrossRefGoogle Scholar
  19. 19.
    Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006) Detrimental contribution of the Toll-like receptor (TLR) 3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2(6):e53PubMedCrossRefGoogle Scholar
  20. 20.
    Wu Y, Wang Y, Zhan J (2009) Effects of remifentanyl and fentanyl on LPS-induced cytokine release in human whole blood in vitro. Mol Biol Rep 36(5):1113–1117PubMedCrossRefGoogle Scholar
  21. 21.
    Heil F, Hemmi H, Hochrein H et al (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526–1529PubMedCrossRefGoogle Scholar
  22. 22.
    Baldwin SL, Shaverdian N, Goto Y, Duthie MS, Raman VS, Evers T, Mompoint F, Vedvick TS, Bertholet S, Coler RN, Reed SG (2009) Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine 27(43):5956–5963PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Department of ImmunologyHarbin Medical UniversityHarbinChina
  2. 2.Department of RespiratoryThe Second Affiliated Hospital of Harbin Medical UniversityHarbinPeople’s Republic of China

Personalised recommendations